These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6687575)

  • 1. [The effects of plasma exchange upon patients with malignant exophthalmos due to Graves' disease].
    Fukino O; Tamai H; Kimura T; Nakagawa T; Inaba S; Kuma K; Kubota K; Kuzuya N; Uchimura H; Nagataki S
    Nihon Naibunpi Gakkai Zasshi; 1983 Jan; 59(1):72-80. PubMed ID: 6687575
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
    Kuzuya N; Chiu SC; Ikeda H; Uchimura H; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1979 Apr; 48(4):706-11. PubMed ID: 581876
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
    Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
    J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Orgiazzi J
    J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid gland in Graves' disease: victim or culprit?
    Chopra IJ; Solomon DH; Johnson DE; Chopra U
    Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
    Wong ET; Doe RP
    Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of triiodothyronine on cervical lymphoid structures, thyroid activity, IgG and IgM immunoglobulin level and exophthalmos in Graves' disease.
    Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Nagel N; Levin S
    Acta Endocrinol (Copenh); 1969 Jul; 61(3):400-6. PubMed ID: 4184992
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of Graves' disease and endocrine exophthalmos.
    Anderson DR
    Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
    [No Abstract]   [Full Text] [Related]  

  • 10. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of serum thyroid-stimulating immunoglobulin and its clinical significance in patients with Graves' disease].
    Leng S
    Zhonghua Yi Xue Za Zhi; 1984 Apr; 64(4):200-2. PubMed ID: 6147186
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease.
    Pittman JG; Maloof F
    Am J Med Sci; 1972 Dec; 264(6):499-505. PubMed ID: 4119609
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-acting thyroid stimulator in Graves' disease.
    Sellers EA; Awad AG; Schönbaum E
    Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simultaneous determination of thyrotropic hormone and long-acting thyroid stimulator in the plasma of patients with Graves' disease].
    Földes J; Gesztesi E; Takács I
    Klin Wochenschr; 1971 May; 49(9):554-7. PubMed ID: 4102376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Familial Basedow's disease in 3 generations].
    Gilbert-Dreyfus ; Peillon F; Doucet D
    Ann Med Interne (Paris); 1972 Nov; 123(11):937-40. PubMed ID: 4679054
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationships among immunoglobulin markers in Graves' disease.
    Ozawa Y; Maciel RM; Chopra IJ; Solomon DH; Beall GN
    J Clin Endocrinol Metab; 1979 Mar; 48(3):381-7. PubMed ID: 581874
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
    Hyman BN; Johnson PC
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
    [No Abstract]   [Full Text] [Related]  

  • 20. Absence of thyroid-binding immunoglobulins in patients with thyrotropin-mediated hyperthyroidism.
    Kourides IA; Pekonen F; Weintraub BD
    J Clin Endocrinol Metab; 1980 Aug; 51(2):272-4. PubMed ID: 6105164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.